[1] Senzolo M, Simioni P, Andriulli A,et al.Screening and treatment of portal vein thrombosis in cirrhosis. Dig Liver Dis, 2017,49:228-229.
[2] Abdel-Razik A, Mousa N, Elhelaly R,et al.De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol, 2015,27:585-592.
[3] Libourel EJ, Klerk CP, van Norden Y,et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood, 2016,128:1854-1861.
[4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版). 中国肝脏病杂志(电子版), 2015,7:1-18.
[5] DeLeve LD,Valla DC,Garcia-Tsao G,et al. Vascular disorders of the liver. Hepatology, 2009,49:1729-1764.
[6] Taylor FB Jr,Toh CH,Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 2001,86:1327-1330.
[7] Dai J, Qi X,Li H,et al. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis. Saudi J Gastroenterol, 2015,21:165-174.
[8] Francoz C,Belghiti J,Vilgrain V,et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut, 2005,54:691-697.
[9] Violi F,Corazza RG,Caldwell SH,et al. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Intern Emerg Med, 2016,11:1059-1066. |
